University Hospital Schleswig-holstein
Clinical trials sponsored by University Hospital Schleswig-holstein, explained in plain language.
-
Could vitamin B3 tame gut inflammation?
Disease control Recruiting nowThis study tests a special form of vitamin B3 (nicotinamide) that releases in the lower gut to treat mild to moderate ulcerative colitis. About 459 adults will receive either a low or high dose of the vitamin or a placebo. The goal is to see if it can reduce symptoms and improve …
Phase: PHASE2, PHASE3 • Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could 3 radiation sessions be enough for prostate cancer?
Disease control Recruiting nowThis study is testing a new, shorter radiation treatment for men with early-stage prostate cancer. Instead of the usual 5 sessions, doctors will give 3 high-dose radiation treatments. The goal is to see if this approach is safe and causes fewer side effects while still controllin…
Phase: NA • Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for genital eczema: drug trial targets severe itch and pain
Disease control Recruiting nowThis study tests whether tralokinumab, an approved eczema drug, can improve moderate-to-severe atopic dermatitis in the genital area. About 30 adults will receive the drug and be monitored for 52 weeks using special skin imaging and symptom questionnaires. The goal is to see if i…
Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for UC patients: early biologic treatment may beat standard therapy
Disease control Recruiting nowThis study compares two treatment approaches for people newly diagnosed with moderate-to-severe ulcerative colitis (UC). One group gets early treatment with mirikizumab, a biologic drug, while the other starts with standard azathioprine pills and can switch to mirikizumab later i…
Phase: PHASE4 • Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a Vitamin-Like pill stop prediabetes from becoming diabetes?
Prevention Recruiting nowThis phase II trial tests whether a special form of nicotinic acid (a B vitamin) can reverse prediabetes and prevent type 2 diabetes. About 390 adults with prediabetes will take either a low or high dose of the drug or a placebo daily for 26 weeks, along with lifestyle advice. Th…
Phase: PHASE2 • Sponsor: University Hospital Schleswig-Holstein • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Sweet cravings in Parkinson's: could sugar be a clue?
Knowledge-focused Recruiting nowThis study looks at why many people with Parkinson's disease eat more sugary foods. Researchers will give 50 participants a sugary drink or a placebo on different days, then measure blood sugar, insulin, and movement symptoms. The goal is to see if fast-acting sugars temporarily …
Sponsor: University Hospital Schleswig-Holstein • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Can we spot Parkinson's before it starts? major screening study launches
Knowledge-focused Recruiting nowThis study is screening 2,000 people aged 50 to 99 who may have a higher risk of developing Parkinson's disease. Researchers will follow participants for five years to track early changes in risk markers and symptoms. The goal is to better understand how Parkinson's develops and …
Sponsor: University Hospital Schleswig-Holstein • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Preeclampsia aftermath: new study tracks heart and kidney risks
Knowledge-focused Recruiting nowThis study follows 100 women who had preeclampsia, HELLP syndrome, or kidney problems during pregnancy. Researchers will measure blood vessel stiffness and collect blood samples for a biobank. The goal is to better understand long-term heart and kidney health after these conditio…
Sponsor: University Hospital Schleswig-Holstein • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:37 UTC